| [1] |
WU Zhiyong, LIU Bingrong, LI Bin, TANG Rui.
Value of red blood cell distribution width in predicting early poor neurologic improvement after intravenous thrombolysis in patients with ischemic stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 307-314.
|
| [2] |
ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin.
Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
|
| [3] |
XU Honglei, XU Bingxin, ZU Qing, ZHAO Yan, GAO Pengfei, YU Yang.
Effects of CYP2C19 gene polymorphism on the clinical prognosis of clopidogrel in elderly patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1014-1020.
|
| [4] |
XIE Yuewu, ZHANG Fang, GUO Yan.
Correlation between cerebral blood flow and infarct volume of the middle cerebral artery occlusion in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 501-506.
|
| [5] |
WANG Meihua, WENG Qiuyan, ZHA Qin, NIU Yanfang.
Effect of Xuesaitong soft capsule on acute lacunar cerebral infarction combined with cerebral microbleeds
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(5): 574-579.
|
| [6] |
LI Lin, HUANG Ji-han, ZHANG Guang-min, LIU Chuan-gui, ZHANG Ping, XIE Xue-feng, HUANG Xiao-hui.
Effects and safety of Xinmaining for cerebral infarction treatment:a systematic review
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1025-1032.
|
| [7] |
MA Ling-song, CHU Zhao-hu, ZHAO Shou-cai.
Effect of Dengzhan shengmai capsules on the secondary prevention of atherosclerotis cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 442-445.
|
| [8] |
YAN Tao, ZHOU Qi-xin, FEI Hui-zhi, HU Xiao-ya, YANG Qiu-jun.
A Meta-analysis for hemorrheologic parameters in patients with cerebral infarction or high risk population treated by Shuxuetong or Danshen
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(3): 302-307.
|
| [9] |
CHENG Ye-dong.
Clinical analysis on 80 patients with large area cerebral infarction of secondary temperature increased and recent prognosis relationship
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 325-327.
|
| [10] |
ZHANG Liu-fu, ZHU You-ling, WANG Guo-hong.
Association study between plasma lipid, carotid artherosclerosis and acute stroke
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(9): 1056-1059.
|
| [11] |
MAO Xin-lei, HAN Li-ya, HUANG Xiang-dong, GUAN Chao-hong, YAN Xue-qin, CHEN Wei-dong.
Analysis on the influencing factors of cerebral infarction patients with aspirin prevention failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(10): 1148-1151.
|
| [12] |
LE Chun, XU Hai-song.
Analysis of deproteinized extract of calf blood (DECB) in treatment of ischemic cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(8): 937-940.
|
| [13] |
JIANG Ya-bin, HUANG Li-an, WANG Tong-ge, HUANG Shun-shao, CHEN Zhuo-ming.
Clinical observation on combining edaravone with breviscapine in treatment of patients with acute cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(7): 808-811.
|
| [14] |
SHI Qing-ping, DING Feng, ZHU Jin-xiu, CHENG Peng, XU Shan-chu, LIU Yan.
A Meta analysis on the effectiveness and safety of Mailuoning injection on cerebral infarction system
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(6): 650-654.
|
| [15] |
GAO Li-li, TANG Yong-chun, LIU Qian, LI Bin.
Clinical effects of combination therapy with sodium ozagrel and low molecular weight heparin on progressive cerebral infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(3): 336-339.
|
